These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26855171)

  • 61. A
    Fischer Z; Das R; Shipman A; Fan JY; Pence L; Bouyain S; Dobens LL
    Dis Model Mech; 2017 Dec; 10(12):1453-1464. PubMed ID: 29025897
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TRIB3 facilitates glioblastoma progression via restraining autophagy.
    Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
    Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
    Lien EC; Lyssiotis CA; Cantley LC
    Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity.
    Geng T; Hu W; Broadwater MH; Snider JM; Bielawski J; Russo SB; Schwacke JH; Ross J; Cowart LA
    Diabetologia; 2013 Sep; 56(9):2078-87. PubMed ID: 23820633
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
    Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
    Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 69. UPR-mediated TRIB3 expression correlates with reduced AKT phosphorylation and inability of interleukin 6 to overcome palmitate-induced apoptosis in RINm5F cells.
    Nicoletti-Carvalho JE; Nogueira TC; Gorjão R; Bromati CR; Yamanaka TS; Boschero AC; Velloso LA; Curi R; Anhê GF; Bordin S
    J Endocrinol; 2010 Aug; 206(2):183-93. PubMed ID: 20488947
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TRIB3-P62 interaction, diabetes and autophagy.
    Hua F; Hu ZW
    Oncotarget; 2015 Oct; 6(33):34061-2. PubMed ID: 26474463
    [No Abstract]   [Full Text] [Related]  

  • 71. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
    Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN
    Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signaling.
    Fulda S
    Mitochondrion; 2014 Nov; 19 Pt A():85-7. PubMed ID: 24780492
    [TBL] [Abstract][Full Text] [Related]  

  • 75. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.
    Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
    Sci Rep; 2016 Mar; 6():23884. PubMed ID: 27029904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals.
    Mannino GC; Averta C; Fiorentino TV; Succurro E; Spiga R; Mancuso E; Miceli S; Perticone M; Sciacqua A; Andreozzi F; Sesti G
    Cardiovasc Diabetol; 2021 May; 20(1):115. PubMed ID: 34051802
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.
    Shimizu T; Tolcher AW; Papadopoulos KP; Beeram M; Rasco DW; Smith LS; Gunn S; Smetzer L; Mays TA; Kaiser B; Wick MJ; Alvarez C; Cavazos A; Mangold GL; Patnaik A
    Clin Cancer Res; 2012 Apr; 18(8):2316-25. PubMed ID: 22261800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
    Mabuchi S; Kuroda H; Takahashi R; Sasano T
    Gynecol Oncol; 2015 Apr; 137(1):173-9. PubMed ID: 25677064
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.